Yüklüyor......
Clarifying the pharmacodynamics of tecemotide (L-BLP25)-based combination therapy
The results of a recently completed Phase III clinical trial suggest that concurrent chemoradiotherapy followed by tecemotide provides superior benefits to Stage IIIa and IIIb non-small cell lung carcinoma patients as compared with sequential chemoradiotherapy followed by tecemotide. These clinical...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3896473/ https://ncbi.nlm.nih.gov/pubmed/24498545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26285 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|